Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive-driven ADL Impairment as a Predictor for Parkinson's Disease Dementia (PDD)

NCT03687203 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT03687203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03687203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive-driven ADL Impairment as a Predictor for Parkinson's Disease Dementia (PDD)
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
July 20, 2018
Completion date
January 31, 2021
Enrollment
182 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease